SOFIA (Bulgaria), February 2 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] posted a preliminary non-consolidated net profit of 25.2 million levs ($14.6 million/12.9 million euro) in 2014, down by more than 25% from a year earlier.